Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Quality of life in inflammatory neuropathies: the IN-QoL.

Draak THP, Faber CG, Merkies ISJ; PeriNomS study Group.

J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316634. doi: 10.1136/jnnp-2017-316634. [Epub ahead of print]

PMID:
28986470
2.

230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24-26 February 2017.

Pruppers MHJ, Merkies ISJ, Lunn MPT, Notermans NC; IMAGiNe Study Group.

Neuromuscul Disord. 2017 Aug 2. pii: S0960-8966(17)31208-7. doi: 10.1016/j.nmd.2017.08.001. [Epub ahead of print] No abstract available.

PMID:
28927829
3.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.

Merkies ISJ, Lawo JP, Edelman JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, L├ęger JM; PRIMA trial investigators.

J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204. No abstract available.

PMID:
28594116
4.

Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.

Waxman SG, Merkies ISJ, Gerrits MM, Dib-Hajj SD, Lauria G, Cox JJ, Wood JN, Woods CG, Drenth JPH, Faber CG.

Lancet Neurol. 2014 Nov;13(11):1152-1160. doi: 10.1016/S1474-4422(14)70150-4. Review.

PMID:
25316021

Supplemental Content

Loading ...
Support Center